Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters

To examine the effects of smoking on first and second trimester screening markers and to determine the overall impact of these effects on Down syndrome and trisomy 18 risks in first trimester combined, second trimester quadruple and integrated tests.

[1]  J. Canick,et al.  Adjustment of Serum Markers in First Trimester Screening , 2009, Journal of medical screening.

[2]  N. Wald,et al.  First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free β human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency , 2008, Journal of medical screening.

[3]  Jean Lambert,et al.  Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy , 2008, Prenatal diagnosis.

[4]  H. Nasrat,et al.  The effect of cigarette or sheesha smoking on first‐trimester markers of Down syndrome , 2007, BJOG : an international journal of obstetrics and gynaecology.

[5]  K. Kagan,et al.  Dose dependency between cigarette consumption and reduced maternal serum PAPP‐A levels at 11–13+6 weeks of gestation , 2007, Prenatal diagnosis.

[6]  ممدوح عبد الله قاري,et al.  The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome , 2007 .

[7]  A. B. Yiğiter,et al.  Effect of smoking on pregnancy-associated plasma protein A, free β-human chorionic gonadotropin, and nuchal translucency in the first trimester of pregnancy , 2006, Advances in therapy.

[8]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.

[9]  D. Krantz,et al.  Maternal weight and ethnic adjustment within a first‐trimester Down syndrome and trisomy 18 screening program , 2005, Prenatal diagnosis.

[10]  K. Spencer,et al.  Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro‐Caribbean populations , 2005, Prenatal diagnosis.

[11]  K. Nicolaides,et al.  The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy , 2004, Prenatal diagnosis.

[12]  M. Ryynänen,et al.  The influence of smoking on the pregnancy‐associated plasma protein A, free β human chorionic gonadotrophin and nuchal translucency , 2003, BJOG : an international journal of obstetrics and gynaecology.

[13]  N J Wald,et al.  First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). , 2003, Health technology assessment.

[14]  A. Rudnicka,et al.  Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance , 2002, Prenatal diagnosis.

[15]  J. Connor,et al.  Maternal smoking: age distribution, levels of alpha‐fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second‐trimester screening , 2002, Prenatal diagnosis.

[16]  S. Ristić,et al.  The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening , 2002, Fetal Diagnosis and Therapy.

[17]  H. Cuckle,et al.  Co‐variables in first trimester maternal serum screening , 2000, Prenatal diagnosis.

[18]  K. Spencer.  The influence of smoking on maternal serum PAPP‐A and free beta hCG levels in the first trimester of pregnancy , 1999, Prenatal diagnosis.

[19]  H. Cuckle,et al.  The effect of smoking in pregnancy on maternal serum inhibin A levels , 1999, Prenatal diagnosis.

[20]  J. Canick,et al.  Second‐trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops , 1998, Prenatal diagnosis.

[21]  K. Spencer.  The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome , 1998, Prenatal diagnosis.

[22]  A. Carbonara,et al.  Influence of smoking habits on Down’s syndrome risk evaluation at mid-trimester through biochemical screening , 1998, International journal of clinical & laboratory research.

[23]  A. Mcguire,et al.  Antenatal screening for Down's syndrome. , 1992, Journal of medical screening.

[24]  J. Haddow,et al.  REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTS , 1996, Prenatal diagnosis.

[25]  J. Haddow,et al.  MULTIPLE MARKER SCREENING FOR DOWN SYNDROME IN TWIN PREGNANCIES , 1996, Prenatal diagnosis.

[26]  J. Canick,et al.  Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin , 1995, Prenatal diagnosis.

[27]  J. Haddow,et al.  Effect of Parity on Human Chorionic Gonadotropin Levels and Down's Syndrome Screening , 1995, Journal of medical screening.

[28]  J. Canick,et al.  Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. , 1993, Obstetrics and gynecology.

[29]  I. Bartels,et al.  Adjustment formulae for maternal serum alpha‐fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking , 1993, Prenatal diagnosis.

[30]  J. Canick,et al.  The effect of smoking in pregnancy on maternal serum alpha‐fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels , 1990, British journal of obstetrics and gynaecology.